Abstract
The present study does not suggest that somatostatin-14 is handled by the kidney in a manner that is qualitatively different from other small peptides but it appears that the kidney plays only a relatively minor role in the in vivo clearance in comparison to the many other sites of degradation.
Original language | English |
---|---|
Pages (from-to) | 151-152 |
Number of pages | 2 |
Journal | Hormone and Metabolic Research |
Volume | 16 |
Issue number | 3 |
DOIs | |
Publication status | Published - 1984 |
Externally published | Yes |
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Biochemistry
- Endocrinology
- Clinical Biochemistry
- Biochemistry, medical